Prevalence and antibiotic susceptibility of ESKAPE pathogens in skin and soft tissue infections
Indian Journal of Dermatology, Venereology and Leprology · 2025
DOI: 10.25259/ijdvl_417_2025 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Indian Journal of Dermatology, Venereology and Leprology, 2025. Verfasst von Kumari Neha Singh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Soft Tissue Infections, Anti-Bacterial Agents, Skin Diseases, Bacterial. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
Skin and soft tissue infections (SSTIs) encompass a wide range of conditions, from superficial infections to life-threatening necrotising fasciitis. Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. (ESKAPE pathogens) are leading causes of SSTIs and are notable for their antimicrobial resistance.
Aim
This study aims to determine the prevalence of SSTIs and analyse the resistance patterns of ESKAPE pathogens,providing critical insights for effective treatment strategies.
Methods
A prospective, observational, cross-sectional study was conducted from January to December 2024 in the Bacteriology section of the Department of Microbiology. A total of 2,300 clinical specimens, including pus, pus swabs, and tissue samples, were processed using standard microbiological techniques. Isolates were identified, and antibiotic susceptibility was assessed following the Clinical and Laboratory Standards Institute (CLSI) guidelines.
Results
Among 2,300 samples, 1,311 (57%) were culture-positive, with ESKAPE pathogens detected in 808 (61.6%) culture-positive isolates. Staphylococcus aureus (59.5%) was the most frequently isolated organism, followed by Pseudomonas aeruginosa (17.8%) and Klebsiella pneumoniae (11.4%). Methicillin-resistant S. aureus (MRSA) was found in 52.2% of isolates. Among Gram-negative bacteria, 15.3% were multidrug-resistant (MDR), but all remained susceptible to colistin.
Limitations
Conducted at a single centre he study may not capture regional differences in resistance, patient demographics, or healthcare practices, nor assess sustained intervention outcomes or relapses.
Conclusion
ESKAPE pathogens contribute significantly to SSTIs, posing a challenge due to their resistance mechanisms. The high prevalence of MRSA and MDR Gram-negative bacteria highlights the need for continuous surveillance, rational antibiotic use, and alternative treatment strategies to combat antimicrobial resistance effectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh, India.
- Department of Dermatology, All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh, India.
- Department of Emergency Medicine, All India Institute of Medical Sciences, Patna, India.
Zitieren
APA
Singh, K. N., Agarwal, K., Singh, P., Rukadikar, A. R., Hada, V., Mohanty, A., Rana, S., Rahul, A., & Mishra, S. (2025). Prevalence and antibiotic susceptibility of ESKAPE pathogens in skin and soft tissue infections. Indian Journal of Dermatology, Venereology and Leprology. https://doi.org/10.25259/ijdvl_417_2025
Vancouver
Singh KN, Agarwal K, Singh P, Rukadikar AR, Hada V, Mohanty A, et al. Prevalence and antibiotic susceptibility of ESKAPE pathogens in skin and soft tissue infections. Indian Journal of Dermatology, Venereology and Leprology. 2025. doi:10.25259/ijdvl_417_2025
BibTeX
@article{Singh2025,
author = {Singh, Kumari Neha and Agarwal, Krati and Singh, Parul and Rukadikar, Atul R and Hada, Vivek and Mohanty, Aroop and Rana, Shivangi and Rahul, Aaruni and Mishra, Shailja},
title = {Prevalence and antibiotic susceptibility of ESKAPE pathogens in skin and soft tissue infections},
journal = {Indian Journal of Dermatology, Venereology and Leprology},
year = {2025},
doi = {10.25259/ijdvl_417_2025}
}
EUVIMED